openPR Logo
Press release

Uveitis treatment Market Trends, Share, Growth, Analysis and Forecast - 2025

07-15-2020 02:03 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Uveitis treatment Market

Uveitis treatment Market

The global uveitis treatment market is projected to exhibit a significant growth, at a CAGR of around 6.1%, during the forecast period. The increasing prevalence of uveitis with the rising autoimmune disorders and eye-related disorders have been offering growth to the uveitis treatment market. The growing government initiatives to aware population and provide better healthcare facilities are further creating enormous growth opportunities for the uveitis treatment market in the emerging nations, such as India and China. In addition, the increasing healthcare expenditure and growing medical industry will escalate the market growth during the forecast period. An increasing number of hospitals and ophthalmic clinics in emerging economies are providing immense growth opportunities for the uveitis treatment market.

Get Sample Copy of Uveitis treatment Market at: https://www.omrglobal.com/request-sample/uveitis-treatment-market

The key players operating in the global uveitis treatment market include AbbVie Inc., Alimera Sciences, Inc., Santen Pharmaceutical Co., Ltd., Allergan PLC, Cadila Pharmaceuticals Ltd., and EyePoint Pharmaceuticals, Inc.

Such factors have further propelled the need for advanced treatment solutions for uveitis. A new journey can be expected in the uveitis treatment market with the introduction of the novel delivery systems across the globe. This includes the introduction of Iontophoresis for the treatment of anterior uveitis. Iontophoresis refers to the use of an electric current, to propel molecules over the hydrophilic cornea epithelium, which is one of the largest roadblocks to drug penetration in an eye. This expectedly increase the bioavailability of medications, such as steroids, allowing greater reduction in the frequency doses and increase in efficiency, when compared to topical corticosteroids.

Moreover, in May 2018, Clearside Biomedical Inc. introduced novel drug therapy for the treatment of back-of-the-eye diseases. The company announced the attainment for the positive topline results from its new Phase 3 clinical trial of suprachoroidal CLS-TA in patients dealing with macular edema associated with non-infectious uveitis. As per the survey, nearly 47% of patients who were given suprachoroidal CLS-TA for around 12 weeks continuously have gained around 15 letters in best corrected visual acuity (“BCVA”), as measured using the Early Treatment of Diabetic Retinopathy Study (“ETDRS”) scale.

For More Information, get A full report of Uveitis treatment Market is available at: https://www.omrglobal.com/industry-reports/uveitis-treatment-market

Moreover, the trial was well tolerated, with no report of any kind of the serious adverse events during the trial.

Intravitreal Sirolimus is another treatment solution available for the uveitis. It is an immunomodulating agent that reduces the number of T-cells and inflammatory cytokines in the patient’s body. Oral sirolimus is widely used for the treatment of posterior uveitis; however, due to its certain side effects, the physicians do not recommend. There is an ongoing phase 3 study for the investigation of intravitreal sirolimus for the treatment of non-infectious posterior uveitis treatment. In addition, the intravitreal sirolimus has a lower rate of side effects as compared to intravitreal corticosteroids. Such development in the uveitis treatment solutions will drive the market growth during the forecast period.

Global uveitis treatment Market-Segmentation

By Disease Type

• Anterior Uveitis
• Posterior Uveitis
• Intermediate Uveitis
• Pan Uveitis

By Treatment Type

• Corticosteroids
• Immunosuppressant
• Monoclonal Antibodies
• Cycloplegic Agents
• Others (Antiviral and Antibiotics)

Global uveitis treatment Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/uveitis-treatment-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis treatment Market Trends, Share, Growth, Analysis and Forecast - 2025 here

News-ID: 2090546 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for Uveitis

Uveitis Market : An Overview Report
Introduction: Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &